logo

For the Inventor, By the Inventor

Daejeon, South Korea

Nakyen Choy

This inventor holds 7 USPTO granted patents. Top assignees: Lg Chemical Ltd., Lucky Limited. Active years: 1996-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nakyen Choy. Retrieved from https://idiyas.com/inventor/nakyen-choy-1mfcvw11

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 9.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal4 out of 83 
 
Lg Chemical Ltd.
 patents
silverMedal3 out of 76 
 
Lucky Limited
 patents

Years Active: 1996-1998

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5773468 - Irreversible HIV protease inhibitor having an anti-aids activity and (1998-06-30),
2. 5763631 - Irreversible HIV protease inhibitors, intermediates, compositions and (1998-06-09),
3. 5744621 - Irreversible HIV protease inhibitors, intermediates, compositions and (1998-04-28),
4. 5696134 - Irreversible HIV protease inhibitors, intermediates, compositions and (1997-12-09),
5. 5679687 - Irreversible HIV protease inhibitors, compositions containing same and (1997-10-21),
6. 5670517 - Irreversible HIV protease inhibitors, compositions containing same and (1997-09-23),
7. 5587388 - Irreversible HIV protease inhibitors, intermediates, compositions and (1996-12-24),

Title: Nakyen Choy: Innovator in HIV Research

Introduction

Nakyen Choy is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of HIV protease inhibitors. With a total of 7 patents to his name, Choy's work has the potential to impact the treatment of HIV infections.

Latest Patents

Choy's latest patents include an irreversible HIV protease inhibitor that exhibits anti-AIDS activity. This invention relates to a novel compound of formula (I) and its pharmaceutically acceptable salts, hydrates, and solvates. The compound serves as an irreversible HIV protease inhibitor, and the patent outlines a process for its preparation, as well as a pharmaceutical composition containing the compound as an active ingredient. This composition is useful for treating or preventing diseases caused by HIV infection. Another significant patent involves cis-epoxide compounds of formula (I-3) and their pharmaceutically acceptable salts, hydrates, and solvates, where R^1 is a cycloalkyl or aryl-substituted lower alkyl group.

Career Highlights

Throughout his career, Nakyen Choy has worked with notable companies such as LG Chemical Ltd. and Lucky Limited. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Choy has collaborated with esteemed colleagues, including Heungsik Yoon and Sung Chun Kim. These partnerships have likely enhanced his research capabilities and led to innovative solutions in the field of HIV treatment.

Conclusion

Nakyen Choy's contributions to HIV research through his patents and collaborations highlight his role as a key innovator in the pharmaceutical industry. His work continues to pave the way for advancements in the treatment of HIV infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…